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ABSTRACT. Background and aims: This study ex-
amines whether a three-year change in serum albumin
concentration is associated with subsequent decline in
functional status in older persons. Methods: A total of
588 participants from the Longitudinal Aging Study
Amsterdam aged 65-85 years were followed for six
years. The three-year change in serum albumin was
classified in four groups: chronic low (43 g/L at both
time points), decrease (decrease of 2.4% or more)
from normal to low, decrease but still normal, and sta-
ble normal albumin (reference group). During the sub-
sequent three years, absolute change and a decline of
one standard deviation or more (termed substantial de-
cline) in functional status was assessed. Functional
status was measured in two ways: using performance
tests and self-reported functional ability. Results:
Substantial decline in functional performance and
functional ability was observed in 243 persons (41.3%)
and 133 persons (22.6%), respectively. After adjust-
ment for baseline functional status and potential con-
founders, chronic low albumin and a decrease from
normal to low albumin were associated with a greater
absolute decline in functional -performance and in
self-reported functional ability. Using the outcome
substantial decline in functional status, only decrease
to low serum albumin was associated with decline in
functional ability [odds ratio (OR)=1.97; one-sided
95% Confidence Limit (CL)=1.09]. Conclusions: This
study indicates that chronic low serum albumin is a de-
terminant of decline in functional status. However, a
decrease in serum albumin from normal to low levels
but within the normal range was a stronger determi-
nant of future decline in functional status. Change in
serum albumin level within the normal range mea-
sured between two points in time may be used as a
general marker of future functional decline.
(Aging Clin Exp Res 2005; 17: 297-305)
©2005, Editrice Kurtis
INTRODUCTION
Serum albumin level is commonly regarded as an in-
dicator of nutrition (1, 2) and is known to predict morbidity
and mortality in older persons (3, 4). Until now, few
studies have investigated the association between serum
albumin level and functional status. Two studies found a
cross-sectional association between lower serum albu-
min concentration and limitations in activities of daily liv-
ing (5, 6). Four longitudinal studies found that low serum
albumin was associated with a higher incidence of disability
(7, 8) and with decline in functional status (9). Although
one study did find an association between low serum al-
bumin (<38 g/L) and three-year functional decline, this as-
sociation was not perceived with seven-year functional de-
cline in high-functioning older persons (10). In a previous
study based on the Longitudinal Aging Study Amsterdam
(LASA), no association was found between low serum al-
bumin (43 g/L) and three-year decline in functional
performance (11).
To summarize, low serum albumin has been found to
be associated with functional decline in some studies,
but not in all. Most previous studies were based on a sin-
gle measurement of serum albumin. It is hypothesized that
albumin levels prior to the observed serum albumin level
may explain the inconsistency in the literature. When two
subsequent measurements of serum albumin are taken in-
to account, two possibilities of having a low serum albu-
min can be distinguished: either the serum albumin level
decreased, or it was already low and remained low.
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Fig. 1 - Selection of study sample, Longitudinal Aging Study Amsterdam.
We investigate here whether a decrease in serum al-
bumin or a chronic low serum albumin level are re-
sponsible for the previously observed associations be-
- tween low serum albumin and decline in functional sta-
tus. To our knowledge, no previous studies have inves-
tigated whether a three-year change in serum albumin is
related to subsequent change in functional status. Using
this information, it would be possible to detect per-
sons at risk for functional decline at an early stage,
and prevent them from further decline. This is impor-
tant, since functional decline may lead to deterioration
in the quality of life, the institutionalization of older
persons, and untimely death (12).
The majority of previous studies investigating the as-
sociation between low serum albumin and functional sta-
tus used self-reported measures of functional status rather
than performance-based tests. Performance-based tests are
objective measures, whereas self-reported measurements
are to some extent influenced by mood or other person-
al factors (13). Since neither test measures the same
construct, performance-based tests and self-reported
measures may be considered as being complementary (14,
15), and both measures are used in the present study.
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The present study examines whether a decrease in
serum albumin concentration or chronic low serum al-
bumin are associated with a change in functional status
as assessed by functional performance tests and self-re-
ported functional ability in an elderly community-dwelling
population.
METHODS
Study sample
The LASA is an ongoing interdisciplinary longitudinal
study that focuses on changes in physical, cognitive,
emotional, and social functioning in the aging population
in the Netherlands. Sampling and data collection have
been described in detail elsewhere (16). Briefly, a sample
of older men and women (aged 55-85 years), stratified by
age, sex, urbanization, and expected five-year mortality,
was drawn from the population registers of 11 munici-
palities in areas situated in the west (Amsterdam region),
north-east (Zwolle region) and south (Oss region) of the
Netherlands. At baseline (1992/93), and every three
years thereafter, a new cycle of measurements was carried
out. Each cycle consisted of a face-to-face main interview
and a medical interview. Both interviews were carried out
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at the subject's home by specially trained interviewers, dur-
ing which the functional status of the interviewee was as-
sessed. After the medical interview, a nurse interviewer
collected blood samples. At the three-year follow-up,
only respondents who participated in the main inter-
view at follow-up and who were born before 1931 (aged
65 and older) were asked to participate in a second
medical interview (17). Informed consent was obtained
from all respondents. The study was approved by the
Medical Ethics Committee of the VU_University_Medical
Center in Amsterdam.
Figure 1 shows the selection of the sample relating to
the present study.
Serum albumin
Non-fasting serum samples were obtained and analysed
directly. In Zwolle, analyses were carried out in the labo-
ratory of the ISALA Clinic (Location Weezelanden) at
baseline and three years later, and in Amsterdam in the
laboratory of the Valerius clinic at baseline and in the lab-
oratory of the VU University Medical Center at three-year
follow-up. To control for between-laboratory differences,
we used information from the Dutch Foundation for
Quality Assessment in Clinical Laboratories (SKZL). Every
two months, eight serum samples were sent to the labo-
ratories to be analyzed, and the serum albumin concen-
tration was reported to the SKZL. Using linear regression,
a regression line was fitted using the individual laborato-
ry assessment of serum albumin for each sample and the
overall national mean of the same sample. Separate
lines were fitted for each laboratory, both at baseline
and at three-year follow-up. Using regression equations,
we adjusted serum albumin levels in LASA data.
Serum albumin concentrations (g/L) were determined
using a bromcresol green (BCG) photometric assay in the
laboratory in Zwolle, and at baseline in Amsterdam. At
three-year follow-up, the laboratory of the VU Universi-
ty Medical Center used a bromcresol purple (BCP)
method. To make serum albumin levels comparable, the
levels determined with the BCP method were converted
using a validated formula (18). The coefficient of variation
of serum albumin was less than 2%.
Change in serum albumin was calculated as (T1-T0/
T0)*100 (TO=serum albumin level at baseline 1992/93,
and T1=serum albumin level at three-year follow-up
1995/96). The cut-off point for low serum albumin was
based on 43 g/L, because no single person had a con-
centration of 38 g/L (19) at baseline or at three-year
follow-up, and because the cut-off point of 43 g/L, which
is within the normal range, had been used in previous stud-
ies (11, 20). The cut-off point of 2.4% for albumin
change was based on the lowest quartile of change in
serum albumin in the total study sample. Thus, change in
serum albumin was classified into four categories: chron-
ic low (albumin 543 g/L at TO and T1), decrease from
normal to low (2.4% decrease or more and albumin at
TO>43 g/L and T143 g/L), decrease but still normal
(2.4% decrease or more and albumin at I U ancrT15-43 	
g/L), and stable normal albumin (decrease less than 2.4%
and albumin at TO and T1>43 g/L=reference group).
Functional status
Functional status was measured at three- and six-year
follow-ups by two different measures: functional perfor-
mance and self-reported functional ability.'
__Functional performance__ Functional performance
was measured using three performance-based tests: walk-
ing, repeated chair stands, and putting on and taking off
a cardigan (21). For the walking test, participants were
asked to walk 3 meters, to turn around and to walk back
3 meters as quickly as possible. This test was timed and
scored according to quartiles based on the entire LASA
cohort at three-year follow-up (22): unable (score 0);
10 seconds (score 1); 8-9 seconds (score 2); 7 seconds
(score 3); and 56 seconds (score 4). For repeated chair
stands, participants were asked to fold their arms across
their chest and to stand up five times from a kitchen chair.
Time needed was categorized similarly: unable (score 0);
16 seconds (score 1); 13-15 seconds (score 2); 11-12
seconds (score 3); and 510 seconds (score 4). The time
taken to put on and take off a cardigan was categorized
as: unable (score 0); 16 seconds (score 1); 12-15 seconds
(score 2); 10-11 seconds (score 3); and 5_9 seconds (score
4). Each performance test thus gave a score ranging
from 0 to 4. The sum score provided the overall perfor-
mance score and ranged from 0 to 12, with moderate re-
liability (Cronbach's alpha=0.63 at three-year follow-up
and 0.74 at six-year follow-up). A lower score indicated
poorer functional status. The sum score has been used be- ,
fore and predicts nursing home admission, mortality,
hospitalization, and subsequent disability (14, 15, 22).
Functional ability. Functional ability was assessed
with a six-item self-report questionnaire and was based on
the ability to perform the following activities (23-25):
walking up and down a staircase of 15 steps without stop-
ping; dressing and undressing oneself; sitting down and ris-
ing from a chair; cutting one's own toenails; walking
outside the house for 5 minutes; and use of own means of
transport or public transport. Response categories ranged
from 1 "not able to do the activity" to 5 "no difficulty".
The sum score provides the overall functional ability
score and ranged from 6 to 30, with good reliability
(Cronbach's alpha=0.75 at three-year follow-up and
0.82 at six-year follow-up). A lower score indicates poor-
er functional status.
Couariates
Covariates were selected when referred to as potential
confounders in the literature, and included age, sex, ed-
ucation (low, middle [reference] and high), smoking status
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(never [reference], former, current), alcohol consump-
tion (none [reference], 1-2 drinks daily, more than 2
drinks daily) and smoking (never [reference], former, cur-
rent). Physical activity (minutes per week) in the previous
two weeks was based on the following activities: walking
outside, cycling, light and heavy household activities,
and a maximum of two sports activities. Body mass index
(BMI) was computed as weight in kilograms divided by
height in meters squared. Self-reports of chronic dis-
eases included diabetes_mellitus,_peripheral_artery dis-
ease (PAD) cardiac disease, stroke, -hypertension, pul-
monary disease, arthritis, and cancer. Serum total choles-
terol (mMol/L) was measured using the enzymatic col-
orimetry method with a Hitachi analyser, and serum cre-
atinin (i_tmol/L) was measured using the Jaffè alkaline pi-
crate reaction. For depressive symptoms, the'Center for
Epidemiologic Studies Depression (CES-D) scale was
used ( 6) and a score of X16 was considered to indicate
depression (27). Cognitive functioning was measured us-
ing the Mini-Mental State Examination (MMSE) and a
score of .23 indicated cognitive impairment (28). All
covariates were assessed at the three-year follow-up.
Covariates were missing for some persons: alcohol con-
sumption (n=1), physical activity (n=7), cognitive im-
pairment (n=1), BMI (n=1) and total cholesterol (n=9).
Statistical analyses
All analyses were performed using SPSS 10.1. The out-
come variable change in functional status was used as both
a continuous and dichotomous variable. First, absolute
Table 1 - General characteristics at three-year follow-up of 588 older persons according to subsequent three-year substantial decline in
functional status.
Functional performance Functional ability
Characteristics Substantial No decline Substantial No decline
decline (n=243) (n=312) p-value decline (n=133) (n=437) p-value
Sex, male, n (%) 117 (48.1) 151 (48.4) 0.95 56 (42.1) 221 (50.6) 0.09
Age (yr), mean (SD) 73.8 (6.0) 73.9 (6.1) 0.91 76.1 (6.1) 73.2 (5.9) 0.00
Education, n (%) 0.42 0.03
Low 136 (56.0) 190 (60.9) 91 (68.4) 243 (55.6)
Middle 81 (33.3) 88 (28.2) 32 (24.1) 142 (32.5)
High 26 (10.7) 34 (10.9) 10 (7.5) 52 (11.9)
Smoking, n (%) 0.34 0.29
Never 85 (35.0) 116 (37.2) 56 (42.1) 152 (34.8)
Former 109 (44.9) 148 (47.4) 55 (41.4) 209 (47.8)
Current 49 (20.2) 48 (15.4) 22 (16.5) 76 (17.4)
Alcohol consumption (drinks/d) n (%) 0.24 0.00
None 46 (19.0) 71 (22.8) 45 (34.1) 80 (18.3)
<2 drinks 92 (38.0) 98 (31.4) 41 (31.1) 154 (35.2)
2 drinks 104 (43.0) 143 (45.8) 46 (34.8) 203 (46.5)
BMI (kg/m2), mean (SD) 27.1 (4.3) 26.9 (3.9) 0.52 27.8 (4.4) 26.7 (4.0) 0.00
Physical activity (min/wk), mean (SD) 156.9 (109.6) 157.5 (96.7) 0.95 147.8 (92.4) 161.4 (104.7) 0.19
Prevalent diabetes, n (%) 20 (8.2) 14 (4.5) 0.07 18 (13.5) 18 (4.1) 0.00
Prevalent PAD, n (%) 17 (7.0) 28 (9.0) 0.40 14 (10.5) 33 (7.6) 0.28
Prevalent cardiac disease, n (%) 52 (21.4) 79 (25.3) 0.28 42 (31.6) 91 (20.8) 0.01
Prevalent stroke, n (%) 14 (5.8) 18 (5.8) 1.0 14 (10.5) 21 (4.8) 0.02
Prevalent hypertension, n (%) 48 (19.8) 68 (21.9) 0.54 33 (24.8) 86 (19.7) 0.21
Prevalent pulmonary disease, n (%) 29 (11.9) 41 (13.1) 0.67 23 (17.3) 52 (11.9) 0.11
Prevalent arthritis, n (%) 108 (44.4) 147 (47.1) 0.53 78 (58.6) 187 (42.8) 0.00
Prevalent cancer, n (%) 27 (11.1) 30 (9.6) 0.57 19 (14.3) 45 (10.3) 0.20
Cognitive impairment, n (%) 17 (7.0) 15 (4.8) 0.28 12 (9.1) 23 (5.3) 0.11
Depressive symptoms, n (%) 26 (10.7) 52 (16.7) 0.05 31 (23.7) 52 (12.0) 0.00
Creatinin (umol/L), mean (SD) 89.7 (19.1) 91.5 (19.8) 0.31 92.7 (26.0) 90.3 (18.2) 0.23
Total cholesterol (mmol/L), mean (SD) 5.9 (1.2) -	 6.0 (1.1) 0.63 5.9 (1.0) 5.9 (1.1) 0.93
Functional performance, mean (SD) 8.7 (2.3) 7.1 (2.7) 0.00 6.5 (2.6) 8.1 (2.6) 0.00
Functional ability, mean (SD) 27.9 (3.2) 27.5 (4.2) 0.25 25.9 (4.5) 28.0 (3.6) 0.00
BMI: body mass index, PAD: peripheral artery disease. Substantial decline in functional status was defined as a decline of one standard deviation or more.
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change in functional status score (functional performance
and functional ability) was calculated as the functional
status score at six-year o ow-up minus	 the same score a
three-year follow-up. Second, substantial decline in func-
tional status was defined as a decline of one standard
deviation or more. The standard deviation of change in the
functional performance sum score was 2, and that in the
functional ability sum score was 3 (22).
The association of substantial decline in functional status
with the confounding variables at three-year follow-up was
tested with a chi-square or t-test. Statistical significance_was
considered present at the two-sided p-value of 0.05.
When examining the association between change in
serum albumin and functional status, one-sided statistical
tests were performed at the p-value of 0.05. The reason
for using the one-sided p-value was that we had a one-sid-
ed hypothesis on an unfavorable effect of chronic low
serum albumin and a decrease in serum albumin, re-
spectively. The differences across albumin categories of
mean absolute change and substantial decline in functional
status score were examined with the chi-square test and
analyses of variance. Additionally, the difference in mean
absolute change between the stable normal group and the
other albumin categories was examined with the Bon-
ferroni post-hoc test. The p-value of the two-sided sta-
tistical test in the output from the statistical package was
divided by two to obtain a one-sided p-value.
Multivariate linear regression models were used to ex-
amine the relationship between change in serum albumin
and absolute change in functional status score. Logistic re-
gression models were used to examine the association be-
tween change in serum albumin and substantial function-
al decline. Results are presented as OR or regression co-
efficient with one-sided 95 percent confidence limits (95%
CL). The presentation of confidence intervals is avoided be-
cause one-sided confidence intervals have either zero or in-
finity as the endpoint. The one-sided 95% CL was calcu-
lated by hand using a z-score of 1.65 instead of 1.96,
which is used for two-sided tests. To take regression to the
mean into account, all regression models were first adjusted
model also included covariates which at p<0.20 were
associated with change in serum albumin and either sub-
stantial decline in functional performance or functional abil-
ity. Effect-modification was examined by testing the in-
teraction between the potential covariates and change in
serum albumin, explaining absolute change or substantial
decline in functional status.
RESULTS
The respondents in the present study sample (n=588)
had better cognitive status, lower level of education, high-
er BMI, higher overall performance score, higher overall
functional ability score, and lower serum creatinin con-
centration, were younger, more were of the female gender,
and they reported the presence of heart disease, pul-
monary disease or PAD at three-year follow-up (p<0.05)
less often than excluded persons (n=95 + 30=125, see
Fig. 1). Of the excluded persons, 18.4% had chronic low
serum albumin, 10.4% decreased to low serum albumin,
16.0% decreased but still had normal albumin levels, and
55.2% had stable normal albumin levels.
Of the 588 respondents, 106 persons (18.0%) had
chronic low serum albumin, 54 (9.2%) decreased to low
serum albumin, and 73 (12.4%) decreased but still had
normal albumin levels. In total, 243 persons (41.3%)
showed a substantial decline in functional performance,
and 133 (22.6%) showed a substantial decline in func-
tional ability. Of the 537 persons who had both measures
of functional status, 61 persons (11.4%) showed a sub-
stantial decline in both measures.
Table 1 shows that persons who declined in func-
tional performance had fewer depressive symptoms
compared with the group with no decline. Substantial
decline in functional ability was associated with lower al-
cohol consumption and higher BMI. Furthermore, per- 
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Table 2 - Three-year change in serum albumin concentration in relation to subsequent three-year absolute change in functional status
and substantial decline in functional status.
Change in
serum albumin*
Functional performance (n=555) Functional ability (n=570)
n Mean change
(SD)
Substantial
decline % (n)
n Mean change
(SD)
Substantial
decline % (n)
Chronic low 101 -1.54 (2.62) 46.5 (47) 99 -1.70 (3.72) 27.3 (27)
Decrease to low 51 -1.90 (2.32)t 52.9 (27) . 50 -2.12 (3.35) 38.0 (19)
Decrease but still normal 69 -1.13 (2.21) 42.0 (29) 72 -1.17 (2.86) 19.4 (14)
Stable normal 334 -0.94 (2.48), 41.9 (140) 349 -1.03 (2.97) 20.9 (73)
Overall p-value 0.01 0.23 0.03 0.02
Substantial decline in functional status was defined as a decline of one standard deviation or more. Change in functional status was defined as six-year follow-
up score minus three-year follow-up score. *For definition of albumin categories, see Methods: Serum albumin. tp<0.05 us stable normal group (Bonferroni
post-hoc test).
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Table 3 - Three-year change in functional status according to previous change in serum albumin.
Functional performance Functional ability
Change in serum albumin*
(n=555) (n=570)
(95% CL)t (95%13 CL)t (95% CL)t (95%13 CL)
Chronic low -0.80 -0.65 -0.64 -0.63(-0.37) (-0.22) (-0.05) (-0.04)
Decrease to low -1.02 -0.83 -1.06 -0.79(-0.46) (-0.28) (-0.28) (-0.01)
- Decrease but still normal 0.06 -0.25-- - -0.15 -0.36
-_(044k (0 24)_. (_0.52) 10.30)
Stable normal reference reference reference reference
Linear regression with independent variable albumin categories (vs stable normal albumin group) and with dependent variable: change in functional status; change
in functional status was defined as six-year follow-up score minus three-year follow-up score. (3: regression coefficient; 95% CL: one-sided 95% confidence lim-
it. *For definition of albumin categories see Methods: Serum albumin. tAdjusted for functional status at three-year follow-up; Tadjusted for functional status, age,
sex, body mass index, physical activity, smoking, alcohol consumption, stroke, hypertension, diabetes mellitus and cognitive impairment at three-year follow-up.
sons who declined in functional ability were older, less
educated, and reported stroke, diabetes, heart disease
and arthritis more often, as well as having more de-
pressive symptoms.
The mean change in functional performance and
ability differed by serum albumin category (Table 2). Per-
sons with a decrease to low albumin showed a signifi-
cantly greater decline in functional performance com-
pared with the stable normal albumin group bonferroni
test= 0.03), and tended to show a greater decline in
functional ability compared with the stable normal
group (Pbonferroni test- 0.07). No significant results were
found (ntt- bonferroni test>0.10) for the other change in al-
bumin categories. For substantial decline in functional
performance, no significant differences across serum al-
bumin categories were found, but the categories did dif-
_ fer_in substantial decline in functional ability (Table 2).
Table 3 shows multiple linear regression models
examining the relationship between change in serum al-
bumin and absolute change in functional status. The
chronic low group and the decrease to low serum al-
bumin group had a significantly greater absolute decline
in functional performance scores compared with the sta-
ble normal albumin group. Similar results were found
for functional ability. No significant interactions be-
tween potential covariates and change in serum albumin
were found.
Table 4- shows the multiple logistic regression models
of change in serum albumin and substantial decline in
functional status. Decrease to low albumin was associat-
ed with an increased risk of substantial decline in functional
performance. This association was found to be no longer
statistically significant after being additionally adjusted
for potential confounders. When substantial decline in
Table 4 - Three-year substantial decline in functional status according to previous change in serum albumin concentration.
Functional performance
(n=555)
Functional ability
(n=570)
Change in serum albumin* OR OR OR OR
(95% CL)t (95% CL) (95% CL)t (95% CL)t
Chronic low 1.40 1.28 1.28 1.40
(0.94) (0.83) (0.82) (0.88)
Decrease to low 1.71 1.42 2.16 1.97(1.01) (0.81) (1.25) (1.09)
Decrease but still normal 0.91 1.09 1.02 1.26
(1.45) (0.66) (0.59) (0.71)
Stable normal 1.00 1.00 1.00 1.00
Logistic regression with dependent variable: substantial decline in functional status; substantial decline in functional status was defined as a dedline of one stan-
dard deviation or more. OR: odds ratio; 95% CL: one-sided 95% confidence limit. *For definition of the albumin categories see Methods: Serum albumin. tAd-
justed for functional status at three-year follow-up; Tadjusted for functional status, age, sex, body mass index, physical activity, smoking, alcohol consumption,
stroke, hypertension, diabetes mellitus and cognitive impairment at three-year follow-up.
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functional ability was examined as outcome variable,
persons with a decrease to low serum albumin showed an
increase• ns • "	 • ; • 0	 le compare wi
the stable normal albumin group. No associations were
found for chronic low serum albumin or for decrease
but still normal albumin.
centration (20). In a population-based cohort study in a
developed country such as The Netherlands (1, 2), serum
a • umin concen ra ions are ley o •e ig er com-
pared with hospitalized patients or nursing-home resi-
dents. It is striking that, even at these higher albumin lev-
els, which were within the normal range, clear associa-
tions between change in albumin and subsequent decline
in functional status were observed. Furthermore, ex-
cluded persons (n=95+30=125, see Fig. 1) showed a
greater decrease in serum albumin (2.4% or more) than
the study -sample-. This-may have-produced underesti
mation in the results.
Several biological mechanisms for the observed as-
sociations may be hypothesized. One explanation might
be the inflammation status of the body. Inflammation is
accompanied by the release of pro-inflammatory cy-
tokines such as interleukin-1, interleukin-6, and tumor
necrosis factor a (29), which induce an acute-phase
response, including a decrease in serum albumin (1, 29).
Acute and chronic diseases are associated with inflam-
mation (1). Furthermore, the presence of chronic dis-
eases, such as stroke and coronary heart disease, has
been observed to cause a decline in functional status
(30). Thus, chronic diseases are associated with a de-
crease in serum albumin and functional status. Never-
theless, after adjustment for chronic disease and other
health-related factors, we still observed a relationship be-
tween albumin and decline in functional status. Slightly
more robust results were even found after adjustment for
both baseline diseases and incident diseases between
baseline and three-year follow-up (data not shown).
However, we cannot exclude the possibility that a de-
crease in serum albumin represents sub-clinical disease,
which would increase the risk of decline in functional sta-
tus. Another potential explanation for the observed as-
sociation may be that low serum albumin is an indicator
of poor nutritional status (1, 2). Adjusting for BMI did not
change our findings, nor did adjusting for body weight
change parallel to albumin change (data not shown).
However, other nutritional components may still af-
fect functional decline. Another possible mechanism is
sarcopenia. Low serum albumin is associated with low-
er muscle mass (31). Loss of muscle mass and strength
is defined as sarcopenia, which is a determinant of
poor physical function (32). It should be borne in mind
that, rather than one single mechanism, an interrelation
of several mechanisms together may explain the asso-
ciation between serum albumin and functional decline.
Variables such as BMI, physical activity, stroke, hy-
pertension, diabetes mellitus, depression, and cogni-
tive impairment were treated as potential confounders,
but they may also mediate the relationship between
albumin change and decline in functional status. For ex-
ample, it may be hypothesized that poor nutritional
status causes a reduction in physical activity, leading to
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DISCUSSION
This community-based study shows that change in
serum albumin levels within the normal range is associated
with subsequent risk of functional decline. Persons with a
decrease to low (43 g/L) albumin level especially seemed
to have an increased risk.
Several studies, but not all, have found an association
between low serum albumin and decline in functional
status. We hypothesized that the albumin level pre-
ceding the low serum albumin level may explain the
conflicting results. Our study showed that persons with
a decrease to low serum albumin consistently showed an
increased risk of decline in self-reported functional
ability, while the association with chronic low albu-
min levels was less consistent. Thus, our hypothesis that
the history of serum albumin may influence the asso-
ciation between low serum albumin and subsequent
functional decline is confirmed.
Another explanation for the conflicting results of
earlier studies may be the use of functional ability as out-
come measure. Studies that did find an association used
self-reported measures or evaluations by a geriatrician,
whereas studies that did not find an association used sub-
stantial decline in functional performance or perfor-
mance-test-related questions. In our study, both measures
of functional status were used, since they complement
each other (14, 15) and we found an association only for
functional ability. An additional explanation for con-
flicting results in earlier studies may be the use of func-
tional status in analyses: continuous or dichotomous.
When we used a dichotomised outcome variable — as
most other studies did — only persons with a decrease to
low albumin levels showed an increased risk. When us-
ing absolute change in functional status score as the out-
come, persons with chronic low serum albumin also
experienced a greater decline in functional status score
compared with the stable normal albumin group. This in-
dicates that these persons may be at risk for some de-
cline in functional status score, but do not satisfy the strict
criteria of substantial decline in functional status. Thus,
the method for assessing functional status, and how
the functional status variable is used in analyses may al-
so explain the inconsistency in the literature.
Low serum albumin concentration is commonly de-
fined as levels of 38 g/L or below (19). Since not a sin-
gle participant had an albumin concentration below 38
g/L at baseline or three years later, we used 43 g/L as
the cut-off point for (chronic) low serum albumin con-
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a decline in functional performance. Adjusting for these
variables ma have resulted in underestimation of the ob-
served associations.
In our study, we used two albumin assessments sep-
arated by a period of three years. Future studies should
examine whether albumin changes during a shorter
time interval are also associated with future functional
decline. For practical use, these studies should determine
which absolute or relative threshold changes in serum al-
bumin-concentration are-still-,---orno-longer,--markers of-
decline in functional status. Nutritional intervention or
anti-inflammatory drugs may help to raise serum albu-
min levels above that threshold and prevent future
functional decline. However, it is also important to
consider other interventions, such as physical activity
training (33), which are known to prevent or delay
functional decline (34).
CONCLUSIONS
In this community-based study, we investigated whether
a three-year change in serum albumin was associated
with subsequent changes in functional performance and
functional ability in older persons. Results confirm that
chronic low serum albumin within the normal range is as-
sociated with a decline in functional status. However,
only low serum albumin caused by a decrease in serum al-
bumin was associated with substantial decline in functional
status. These results suggest that a decrease in serum al-
bumin, based on two measurements taken at different pe-
riods in time, may be used as an early marker of future
functional decline.
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